The MOBILISE study: utilisation of ambulatory pumps in the inpatient setting to administer continuous antibiotic infusions-a randomised controlled trial.


Journal

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
ISSN: 1435-4373
Titre abrégé: Eur J Clin Microbiol Infect Dis
Pays: Germany
ID NLM: 8804297

Informations de publication

Date de publication:
Dec 2021
Historique:
received: 27 03 2021
accepted: 14 06 2021
pubmed: 15 7 2021
medline: 22 12 2021
entrez: 14 7 2021
Statut: ppublish

Résumé

In the inpatient setting, antibiotics are generally administered via bedside pumps with multiple daily dosing. Utilisation of a continuous antibiotic infusion (CAI) instead might have patient and nursing satisfaction, workflow efficiencies and infection control benefits. We aimed to study the utilisation of CAI in the inpatient setting for routine antibiotic administration. Patients receiving a peripherally inserted central venous catheter (PICC) for antibiotic administration were screened for the study. The patients were randomised to either (1) standard pump and intermittent antibiotic administration (IAA) or (2) CAI via an ambulatory pump. An accelerometer placed on the ankle was used to assess patient activity. Nursing and patient satisfaction surveys were also carried out. Forty patients met the study criteria for enrolment with 21 patients being enrolled in the CAI arm of the study. One hundred and five days of accelerometer recordings were available for analysis. The geometric mean activity was 45 min/day in the standard arm and 64 min/day in the CAI arm. This represented a 42% (95% CI: -14 to 133%, p = 0.16) difference in activity between the two groups. Nursing staff reported that they spent less time throughout their shift attending the antibiotic line or pump in patients who were in the CAI arm of the study (p < 0.001). In addition, patients in this arm of the study were more likely to recommend this method of administration of antibiotics to a family member (p =0.0001). The MOBILISE study showed nursing and patient satisfaction when CAI were utilised in the inpatient setting. A statistically non-significant difference in mobility was seen. The trial was registered (28/03/2018) with the Australia New Zealand Clinical Trials Registry (ACTRN12618000452291).

Identifiants

pubmed: 34258686
doi: 10.1007/s10096-021-04294-3
pii: 10.1007/s10096-021-04294-3
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

2505-2513

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

MacKenzie M, Rae N, Nathwani D 2014) Outcomes from global adult outpatient parenteral antimicrobial therapy programmes: a review of the last decade. Int J Antimicrob Agents 7–16
Durojaiye OC et al (2017) Clinical efficacy, cost analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield (UK) OPAT service. Int J Antimicrob Agents
Subedi S et al (2015) Supervised self-administration of outpatient parenteral antibiotic therapy: a report from a large tertiary hospital in Australia. Int J Infect Dis 161–5
Marsh N, Larsen E, Tapp S (2019) Management of hospital in the home (HITH) peripherally inserted catheters: a retrospective cohort study. Home Health Care Manag Pract
Zisberg A, Shadmi E, Sinoff G et al (2011) Low mobility during hospitalisation and functional decline in older adults. J Am Geriatr 266
Australian Injectable Drugs Handbook (2017) Melbourne : Australian Society of Hospital Pharmacists
Therapeutic Guidlines (2019) Melbourne: Therapeutic Guidlines Limited
Baxter (2019) [Online]. https://www.baxterprofessional.com.au .
Berthoin K, Le Duff CS, Marchand-Brynaert, et al (2010) Stability of meropenem and doripenem solutions for administration by continuous infusion. J Antimicrob Chemother 1073–1075
Manning L, Wrigh C et al (2014) Continuous infusions of meropenem in ambulatory care: clinical efficacy, safety, and stability. PLoS ONE e102023
Foy F, Luna G, Martinez J et al (2019) An investigation of the stability of meropenem in elastomeric infusion devices. Drug Des Devel Ther 2655–2665
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap): a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 377–381
Quan H, Chantal B L et al (2010) Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Pract Epidemiol 676–682
Hobbs JG, Ryan MK, Ritchie B et al (2017) Protocol for a randomised crossover trial to evaluate patient and nurse satisfaction with electronic and elastomeric portable infusion pumps for the continuous administration of antibiotic therapy in the home: the Comparing Home Infusion Device study. BMJ Open e016763
Pezzino S, Florenty S, Fagour C et al (2010) Remedial actions for the physical inactivity of hospitalised patients with type 2 diabetes. Diab Care 1960-1961
Elsiger DW, Rowlands AV, Hurst T (2011) Validation of the GENEA Accelerometer. Med Sci Sports Exerc 1085–1093
OBrien J, Paquet F, Lindsay R, Valenti D (2013) Insertion of PICCs with minimum number of lumens reduces complications and costs. J Am Coll Radiol 10(11)

Auteurs

K L McCarthy (KL)

Infectious Diseases Department, Level 6 Joyce Tweddell Building, Royal Brisbane and Women's Hospital, Cnr Butterfield St and Herston Road, Brisbane, QLD, 4029, Australia. Kate.mccarthy@uq.edu.au.
University of Queensland Centre for Clinical Research, Brisbane, QLD, Australia. Kate.mccarthy@uq.edu.au.

T Harris-Brown (T)

University of Queensland Centre for Clinical Research, Brisbane, QLD, Australia.

E J Smits (EJ)

RECOVER Injury Research Centre, University of Queensland, Brisbane, QLD, Australia.

A Legg (A)

Infectious Diseases Department, Level 6 Joyce Tweddell Building, Royal Brisbane and Women's Hospital, Cnr Butterfield St and Herston Road, Brisbane, QLD, 4029, Australia.

M D Chatfield (MD)

University of Queensland Centre for Clinical Research, Brisbane, QLD, Australia.

D L Paterson (DL)

Infectious Diseases Department, Level 6 Joyce Tweddell Building, Royal Brisbane and Women's Hospital, Cnr Butterfield St and Herston Road, Brisbane, QLD, 4029, Australia.
University of Queensland Centre for Clinical Research, Brisbane, QLD, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH